Biotage AB (publ) (BITGF) Stock Competitors & Peer Comparison
See (BITGF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BITGF | $15.01 | +0.00% | 1.2B | 45.50 | $0.33 | N/A |
| SRTOY | $20.56 | +2.06% | 200B | 64.25 | $0.32 | +0.40% |
| ESLOY | $101.65 | +0.11% | 93.7B | 35.29 | $2.89 | +2.30% |
| ESLOF | $202.00 | +0.40% | 93.6B | 34.77 | $5.81 | +2.33% |
| SOAGY | $56.99 | +2.62% | 83.9B | 104.44 | $0.55 | +0.29% |
| HOCPY | $170.09 | -0.97% | 57B | 36.46 | $4.67 | +1.01% |
| HOCPF | $166.17 | +1.98% | 55.6B | 34.84 | $4.77 | +1.15% |
| MECNY | $88.63 | +0.00% | 26.9B | N/A | N/A | N/A |
| TRUMY | $15.04 | -0.66% | 22.3B | 26.07 | $0.58 | +1.14% |
| TRUMF | $15.12 | +2.30% | 22.3B | 26.07 | $0.58 | +1.29% |
Stock Comparison
BITGF vs SRTOY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SRTOY has a market cap of 200B. Regarding current trading prices, BITGF is priced at $15.01, while SRTOY trades at $20.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SRTOY's P/E ratio is 64.25. In terms of profitability, BITGF's ROE is +0.04%, compared to SRTOY's ROE of +0.06%. Regarding short-term risk, BITGF is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SRTOY's competition here
BITGF vs ESLOY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ESLOY has a market cap of 93.7B. Regarding current trading prices, BITGF is priced at $15.01, while ESLOY trades at $101.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ESLOY's P/E ratio is 35.29. In terms of profitability, BITGF's ROE is +0.04%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, BITGF is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check ESLOY's competition here
BITGF vs ESLOF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ESLOF has a market cap of 93.6B. Regarding current trading prices, BITGF is priced at $15.01, while ESLOF trades at $202.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ESLOF's P/E ratio is 34.77. In terms of profitability, BITGF's ROE is +0.04%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, BITGF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check ESLOF's competition here
BITGF vs SOAGY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SOAGY has a market cap of 83.9B. Regarding current trading prices, BITGF is priced at $15.01, while SOAGY trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SOAGY's P/E ratio is 104.44. In terms of profitability, BITGF's ROE is +0.04%, compared to SOAGY's ROE of +0.06%. Regarding short-term risk, BITGF is less volatile compared to SOAGY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SOAGY's competition here
BITGF vs HOCPY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, HOCPY has a market cap of 57B. Regarding current trading prices, BITGF is priced at $15.01, while HOCPY trades at $170.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas HOCPY's P/E ratio is 36.46. In terms of profitability, BITGF's ROE is +0.04%, compared to HOCPY's ROE of +0.25%. Regarding short-term risk, BITGF is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check HOCPY's competition here
BITGF vs HOCPF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, HOCPF has a market cap of 55.6B. Regarding current trading prices, BITGF is priced at $15.01, while HOCPF trades at $166.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas HOCPF's P/E ratio is 34.84. In terms of profitability, BITGF's ROE is +0.04%, compared to HOCPF's ROE of +0.25%. Regarding short-term risk, BITGF is more volatile compared to HOCPF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check HOCPF's competition here
BITGF vs MECNY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, MECNY has a market cap of 26.9B. Regarding current trading prices, BITGF is priced at $15.01, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas MECNY's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, BITGF is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check MECNY's competition here
BITGF vs TRUMY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, TRUMY has a market cap of 22.3B. Regarding current trading prices, BITGF is priced at $15.01, while TRUMY trades at $15.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas TRUMY's P/E ratio is 26.07. In terms of profitability, BITGF's ROE is +0.04%, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, BITGF is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check TRUMY's competition here
BITGF vs TRUMF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, TRUMF has a market cap of 22.3B. Regarding current trading prices, BITGF is priced at $15.01, while TRUMF trades at $15.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas TRUMF's P/E ratio is 26.07. In terms of profitability, BITGF's ROE is +0.04%, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, BITGF is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check TRUMF's competition here
BITGF vs SDMHF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SDMHF has a market cap of 20B. Regarding current trading prices, BITGF is priced at $15.01, while SDMHF trades at $205.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SDMHF's P/E ratio is 63.95. In terms of profitability, BITGF's ROE is +0.04%, compared to SDMHF's ROE of +0.07%. Regarding short-term risk, BITGF is less volatile compared to SDMHF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SDMHF's competition here
BITGF vs SAUHY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SAUHY has a market cap of 19.3B. Regarding current trading prices, BITGF is priced at $15.01, while SAUHY trades at $12.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SAUHY's P/E ratio is 43.21. In terms of profitability, BITGF's ROE is +0.04%, compared to SAUHY's ROE of +0.17%. Regarding short-term risk, BITGF is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SAUHY's competition here
BITGF vs SAUHF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SAUHF has a market cap of 19.1B. Regarding current trading prices, BITGF is priced at $15.01, while SAUHF trades at $119.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SAUHF's P/E ratio is 40.88. In terms of profitability, BITGF's ROE is +0.04%, compared to SAUHF's ROE of +0.17%. Regarding short-term risk, BITGF is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SAUHF's competition here
BITGF vs SUVPF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SUVPF has a market cap of 18.9B. Regarding current trading prices, BITGF is priced at $15.01, while SUVPF trades at $273.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SUVPF's P/E ratio is 100.24. In terms of profitability, BITGF's ROE is +0.04%, compared to SUVPF's ROE of +0.06%. Regarding short-term risk, BITGF is less volatile compared to SUVPF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SUVPF's competition here
BITGF vs SARTF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SARTF has a market cap of 15.7B. Regarding current trading prices, BITGF is priced at $15.01, while SARTF trades at $227.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SARTF's P/E ratio is 83.15. In terms of profitability, BITGF's ROE is +0.04%, compared to SARTF's ROE of +0.06%. Regarding short-term risk, BITGF is more volatile compared to SARTF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check SARTF's competition here
BITGF vs SSSGY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SSSGY has a market cap of 15.4B. Regarding current trading prices, BITGF is priced at $15.01, while SSSGY trades at $44.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SSSGY's P/E ratio is 81.24. In terms of profitability, BITGF's ROE is +0.04%, compared to SSSGY's ROE of +0.06%. Regarding short-term risk, BITGF is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SSSGY's competition here
BITGF vs FSPKF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, FSPKF has a market cap of 12.1B. Regarding current trading prices, BITGF is priced at $15.01, while FSPKF trades at $20.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas FSPKF's P/E ratio is 46.70. In terms of profitability, BITGF's ROE is +0.04%, compared to FSPKF's ROE of +0.23%. Regarding short-term risk, BITGF is more volatile compared to FSPKF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check FSPKF's competition here
BITGF vs AHICF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, AHICF has a market cap of 5.7B. Regarding current trading prices, BITGF is priced at $15.01, while AHICF trades at $21.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas AHICF's P/E ratio is 50.96. In terms of profitability, BITGF's ROE is +0.04%, compared to AHICF's ROE of +0.20%. Regarding short-term risk, BITGF is less volatile compared to AHICF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check AHICF's competition here
BITGF vs SSMXF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SSMXF has a market cap of 5.5B. Regarding current trading prices, BITGF is priced at $15.01, while SSMXF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SSMXF's P/E ratio is 24.58. In terms of profitability, BITGF's ROE is +0.04%, compared to SSMXF's ROE of +0.07%. Regarding short-term risk, BITGF is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SSMXF's competition here
BITGF vs SSMXY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SSMXY has a market cap of 5.4B. Regarding current trading prices, BITGF is priced at $15.01, while SSMXY trades at $8.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SSMXY's P/E ratio is 24.22. In terms of profitability, BITGF's ROE is +0.04%, compared to SSMXY's ROE of +0.07%. Regarding short-term risk, BITGF is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SSMXY's competition here
BITGF vs CNVVY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, CNVVY has a market cap of 5.4B. Regarding current trading prices, BITGF is priced at $15.01, while CNVVY trades at $10.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas CNVVY's P/E ratio is 32.37. In terms of profitability, BITGF's ROE is +0.04%, compared to CNVVY's ROE of +0.10%. Regarding short-term risk, BITGF is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check CNVVY's competition here
BITGF vs CNVVF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, CNVVF has a market cap of 5.1B. Regarding current trading prices, BITGF is priced at $15.01, while CNVVF trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas CNVVF's P/E ratio is 29.06. In terms of profitability, BITGF's ROE is +0.04%, compared to CNVVF's ROE of +0.11%. Regarding short-term risk, BITGF is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check CNVVF's competition here
BITGF vs FLMNF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, FLMNF has a market cap of 4.3B. Regarding current trading prices, BITGF is priced at $15.01, while FLMNF trades at $50.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas FLMNF's P/E ratio is 17.87. In terms of profitability, BITGF's ROE is +0.04%, compared to FLMNF's ROE of +0.22%. Regarding short-term risk, BITGF is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check FLMNF's competition here
BITGF vs FLMNY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, FLMNY has a market cap of 4.2B. Regarding current trading prices, BITGF is priced at $15.01, while FLMNY trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas FLMNY's P/E ratio is 17.43. In terms of profitability, BITGF's ROE is +0.04%, compared to FLMNY's ROE of +0.21%. Regarding short-term risk, BITGF is less volatile compared to FLMNY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check FLMNY's competition here
BITGF vs ANSLF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ANSLF has a market cap of 3.2B. Regarding current trading prices, BITGF is priced at $15.01, while ANSLF trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ANSLF's P/E ratio is 32.49. In terms of profitability, BITGF's ROE is +0.04%, compared to ANSLF's ROE of +0.07%. Regarding short-term risk, BITGF is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check ANSLF's competition here
BITGF vs ANSLY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ANSLY has a market cap of 2.7B. Regarding current trading prices, BITGF is priced at $15.01, while ANSLY trades at $74.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ANSLY's P/E ratio is 19.99. In terms of profitability, BITGF's ROE is +0.04%, compared to ANSLY's ROE of +0.07%. Regarding short-term risk, BITGF is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check ANSLY's competition here
BITGF vs CZMWY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, CZMWY has a market cap of 2.6B. Regarding current trading prices, BITGF is priced at $15.01, while CZMWY trades at $30.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas CZMWY's P/E ratio is 16.15. In terms of profitability, BITGF's ROE is +0.04%, compared to CZMWY's ROE of +0.06%. Regarding short-term risk, BITGF is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check CZMWY's competition here
BITGF vs CZMWF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, CZMWF has a market cap of 2.6B. Regarding current trading prices, BITGF is priced at $15.01, while CZMWF trades at $29.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas CZMWF's P/E ratio is 15.86. In terms of profitability, BITGF's ROE is +0.04%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, BITGF is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check CZMWF's competition here
BITGF vs EKTAF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, EKTAF has a market cap of 2.4B. Regarding current trading prices, BITGF is priced at $15.01, while EKTAF trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas EKTAF's P/E ratio is -43.33. In terms of profitability, BITGF's ROE is +0.04%, compared to EKTAF's ROE of -0.06%. Regarding short-term risk, BITGF is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check EKTAF's competition here
BITGF vs EKTAY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, EKTAY has a market cap of 2.2B. Regarding current trading prices, BITGF is priced at $15.01, while EKTAY trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas EKTAY's P/E ratio is -38.35. In terms of profitability, BITGF's ROE is +0.04%, compared to EKTAY's ROE of -0.00%. Regarding short-term risk, BITGF is more volatile compared to EKTAY. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check EKTAY's competition here
BITGF vs SHWGF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SHWGF has a market cap of 2B. Regarding current trading prices, BITGF is priced at $15.01, while SHWGF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SHWGF's P/E ratio is 8.80. In terms of profitability, BITGF's ROE is +0.04%, compared to SHWGF's ROE of +0.07%. Regarding short-term risk, BITGF is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SHWGF's competition here
BITGF vs ADDLF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ADDLF has a market cap of 1.8B. Regarding current trading prices, BITGF is priced at $15.01, while ADDLF trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ADDLF's P/E ratio is 23.16. In terms of profitability, BITGF's ROE is +0.04%, compared to ADDLF's ROE of +0.11%. Regarding short-term risk, BITGF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check ADDLF's competition here
BITGF vs SHWGY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SHWGY has a market cap of 1.8B. Regarding current trading prices, BITGF is priced at $15.01, while SHWGY trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SHWGY's P/E ratio is 7.67. In terms of profitability, BITGF's ROE is +0.04%, compared to SHWGY's ROE of +0.07%. Regarding short-term risk, BITGF is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SHWGY's competition here
BITGF vs NPRRF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, BITGF is priced at $15.01, while NPRRF trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas NPRRF's P/E ratio is 21.65. In terms of profitability, BITGF's ROE is +0.04%, compared to NPRRF's ROE of N/A. Regarding short-term risk, BITGF is less volatile compared to NPRRF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check NPRRF's competition here
BITGF vs TGLVY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, TGLVY has a market cap of 1.6B. Regarding current trading prices, BITGF is priced at $15.01, while TGLVY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas TGLVY's P/E ratio is 40.00. In terms of profitability, BITGF's ROE is +0.04%, compared to TGLVY's ROE of +0.03%. Regarding short-term risk, BITGF is more volatile compared to TGLVY. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check TGLVY's competition here
BITGF vs PBHDF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, PBHDF has a market cap of 1.2B. Regarding current trading prices, BITGF is priced at $15.01, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, BITGF's ROE is +0.04%, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, BITGF is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check PBHDF's competition here
BITGF vs SAFLY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SAFLY has a market cap of 1.1B. Regarding current trading prices, BITGF is priced at $15.01, while SAFLY trades at $3.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SAFLY's P/E ratio is 13.93. In terms of profitability, BITGF's ROE is +0.04%, compared to SAFLY's ROE of +0.12%. Regarding short-term risk, BITGF is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SAFLY's competition here
BITGF vs GRRMF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, GRRMF has a market cap of 1.1B. Regarding current trading prices, BITGF is priced at $15.01, while GRRMF trades at $32.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas GRRMF's P/E ratio is 40.76. In terms of profitability, BITGF's ROE is +0.04%, compared to GRRMF's ROE of +0.02%. Regarding short-term risk, BITGF is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check GRRMF's competition here
BITGF vs JNDOF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, JNDOF has a market cap of 1.1B. Regarding current trading prices, BITGF is priced at $15.01, while JNDOF trades at $47.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas JNDOF's P/E ratio is 98.38. In terms of profitability, BITGF's ROE is +0.04%, compared to JNDOF's ROE of +0.27%. Regarding short-term risk, BITGF is more volatile compared to JNDOF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check JNDOF's competition here
BITGF vs SAFLF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SAFLF has a market cap of 906.6M. Regarding current trading prices, BITGF is priced at $15.01, while SAFLF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SAFLF's P/E ratio is 16.50. In terms of profitability, BITGF's ROE is +0.04%, compared to SAFLF's ROE of +0.12%. Regarding short-term risk, BITGF is more volatile compared to SAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check SAFLF's competition here
BITGF vs KSRBF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, KSRBF has a market cap of 839.6M. Regarding current trading prices, BITGF is priced at $15.01, while KSRBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas KSRBF's P/E ratio is 33.29. In terms of profitability, BITGF's ROE is +0.04%, compared to KSRBF's ROE of +0.04%. Regarding short-term risk, BITGF is more volatile compared to KSRBF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check KSRBF's competition here
BITGF vs TDVXF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, TDVXF has a market cap of 833.9M. Regarding current trading prices, BITGF is priced at $15.01, while TDVXF trades at $7.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas TDVXF's P/E ratio is 43.89. In terms of profitability, BITGF's ROE is +0.04%, compared to TDVXF's ROE of +0.32%. Regarding short-term risk, BITGF is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check TDVXF's competition here
BITGF vs HGYMF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, HGYMF has a market cap of 754.4M. Regarding current trading prices, BITGF is priced at $15.01, while HGYMF trades at $34.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas HGYMF's P/E ratio is 184.16. In terms of profitability, BITGF's ROE is +0.04%, compared to HGYMF's ROE of +0.00%. Regarding short-term risk, BITGF is less volatile compared to HGYMF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check HGYMF's competition here
BITGF vs NNCSF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, NNCSF has a market cap of 747M. Regarding current trading prices, BITGF is priced at $15.01, while NNCSF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas NNCSF's P/E ratio is 50.00. In terms of profitability, BITGF's ROE is +0.04%, compared to NNCSF's ROE of +0.10%. Regarding short-term risk, BITGF is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check NNCSF's competition here
BITGF vs SPMXF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, BITGF is priced at $15.01, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, BITGF's ROE is +0.04%, compared to SPMXF's ROE of -0.08%. Regarding short-term risk, BITGF is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check SPMXF's competition here
BITGF vs CLHLF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, BITGF is priced at $15.01, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, BITGF's ROE is +0.04%, compared to CLHLF's ROE of +0.16%. Regarding short-term risk, BITGF is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check CLHLF's competition here
BITGF vs TSNLF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, TSNLF has a market cap of 265.4M. Regarding current trading prices, BITGF is priced at $15.01, while TSNLF trades at $5.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas TSNLF's P/E ratio is 25.14. In terms of profitability, BITGF's ROE is +0.04%, compared to TSNLF's ROE of +0.24%. Regarding short-term risk, BITGF is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check TSNLF's competition here
BITGF vs OPSSF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, BITGF is priced at $15.01, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, BITGF's ROE is +0.04%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, BITGF is more volatile compared to OPSSF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check OPSSF's competition here
BITGF vs EEOIF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, BITGF is priced at $15.01, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, BITGF's ROE is +0.04%, compared to EEOIF's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check EEOIF's competition here
BITGF vs OTCFF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, OTCFF has a market cap of 20.9M. Regarding current trading prices, BITGF is priced at $15.01, while OTCFF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas OTCFF's P/E ratio is -13.07. In terms of profitability, BITGF's ROE is +0.04%, compared to OTCFF's ROE of +1.38%. Regarding short-term risk, BITGF is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check OTCFF's competition here
BITGF vs UEEC Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, UEEC has a market cap of 16.4M. Regarding current trading prices, BITGF is priced at $15.01, while UEEC trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas UEEC's P/E ratio is -6.28. In terms of profitability, BITGF's ROE is +0.04%, compared to UEEC's ROE of +0.40%. Regarding short-term risk, BITGF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check UEEC's competition here
BITGF vs BLMHF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, BITGF is priced at $15.01, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, BITGF's ROE is +0.04%, compared to BLMHF's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check BLMHF's competition here
BITGF vs PXMVF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, BITGF is priced at $15.01, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, BITGF's ROE is +0.04%, compared to PXMVF's ROE of -6.46%. Regarding short-term risk, BITGF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check PXMVF's competition here
BITGF vs MCDA Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, BITGF is priced at $15.01, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas MCDA's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to MCDA's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check MCDA's competition here
BITGF vs TUTH Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, TUTH has a market cap of 4.2M. Regarding current trading prices, BITGF is priced at $15.01, while TUTH trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas TUTH's P/E ratio is -1.67. In terms of profitability, BITGF's ROE is +0.04%, compared to TUTH's ROE of +0.27%. Regarding short-term risk, BITGF is more volatile compared to TUTH. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check TUTH's competition here
BITGF vs RSCF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, RSCF has a market cap of 4.1M. Regarding current trading prices, BITGF is priced at $15.01, while RSCF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas RSCF's P/E ratio is -4.75. In terms of profitability, BITGF's ROE is +0.04%, compared to RSCF's ROE of +0.10%. Regarding short-term risk, BITGF is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check RSCF's competition here
BITGF vs CBSC Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, CBSC has a market cap of 3.6M. Regarding current trading prices, BITGF is priced at $15.01, while CBSC trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas CBSC's P/E ratio is -3.20. In terms of profitability, BITGF's ROE is +0.04%, compared to CBSC's ROE of +0.58%. Regarding short-term risk, BITGF is less volatile compared to CBSC. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check CBSC's competition here
BITGF vs NSTGQ Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, BITGF is priced at $15.01, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, BITGF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check NSTGQ's competition here
BITGF vs GVDI Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, GVDI has a market cap of 2.2M. Regarding current trading prices, BITGF is priced at $15.01, while GVDI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas GVDI's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, BITGF is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check GVDI's competition here
BITGF vs YBGJ Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, YBGJ has a market cap of 1M. Regarding current trading prices, BITGF is priced at $15.01, while YBGJ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas YBGJ's P/E ratio is -0.84. In terms of profitability, BITGF's ROE is +0.04%, compared to YBGJ's ROE of +0.37%. Regarding short-term risk, BITGF is more volatile compared to YBGJ. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check YBGJ's competition here
BITGF vs OJSY Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, BITGF is priced at $15.01, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas OJSY's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to OJSY's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check OJSY's competition here
BITGF vs PDMI Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, BITGF is priced at $15.01, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas PDMI's P/E ratio is -0.01. In terms of profitability, BITGF's ROE is +0.04%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, BITGF is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check PDMI's competition here
BITGF vs WHSI Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, BITGF is priced at $15.01, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas WHSI's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, BITGF is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check WHSI's competition here
BITGF vs BLFE Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, BITGF is priced at $15.01, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas BLFE's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to BLFE's ROE of +3.67%. Regarding short-term risk, BITGF is more volatile compared to BLFE. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check BLFE's competition here
BITGF vs ECIA Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ECIA has a market cap of 124.5K. Regarding current trading prices, BITGF is priced at $15.01, while ECIA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ECIA's P/E ratio is -0.33. In terms of profitability, BITGF's ROE is +0.04%, compared to ECIA's ROE of -0.22%. Regarding short-term risk, BITGF is less volatile compared to ECIA. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check ECIA's competition here
BITGF vs QTXB Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, BITGF is priced at $15.01, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas QTXB's P/E ratio is -0.05. In terms of profitability, BITGF's ROE is +0.04%, compared to QTXB's ROE of +0.19%. Regarding short-term risk, BITGF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check QTXB's competition here
BITGF vs LANZ Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, LANZ has a market cap of 110.4K. Regarding current trading prices, BITGF is priced at $15.01, while LANZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas LANZ's P/E ratio is 4.00. In terms of profitability, BITGF's ROE is +0.04%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, BITGF is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check LANZ's competition here
BITGF vs CEOS Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, CEOS has a market cap of 90.4K. Regarding current trading prices, BITGF is priced at $15.01, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas CEOS's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to CEOS's ROE of +7.33%. Regarding short-term risk, BITGF is more volatile compared to CEOS. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check CEOS's competition here
BITGF vs IMTH Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, IMTH has a market cap of 71.8K. Regarding current trading prices, BITGF is priced at $15.01, while IMTH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas IMTH's P/E ratio is -0.02. In terms of profitability, BITGF's ROE is +0.04%, compared to IMTH's ROE of -0.60%. Regarding short-term risk, BITGF is more volatile compared to IMTH. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check IMTH's competition here
BITGF vs GMVDF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, BITGF is priced at $15.01, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas GMVDF's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, BITGF is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check GMVDF's competition here
BITGF vs REMI Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, REMI has a market cap of 14K. Regarding current trading prices, BITGF is priced at $15.01, while REMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas REMI's P/E ratio is -0.07. In terms of profitability, BITGF's ROE is +0.04%, compared to REMI's ROE of -0.11%. Regarding short-term risk, BITGF is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check REMI's competition here
BITGF vs SDCCQ Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SDCCQ has a market cap of 13.4K. Regarding current trading prices, BITGF is priced at $15.01, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, BITGF is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check SDCCQ's competition here
BITGF vs MDIT Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, MDIT has a market cap of 8.7K. Regarding current trading prices, BITGF is priced at $15.01, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas MDIT's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, BITGF is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check MDIT's competition here
BITGF vs ASFX Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ASFX has a market cap of 5.3K. Regarding current trading prices, BITGF is priced at $15.01, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ASFX's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, BITGF is less volatile compared to ASFX. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check ASFX's competition here
BITGF vs DGEN Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, BITGF is priced at $15.01, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas DGEN's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, BITGF is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check DGEN's competition here
BITGF vs SVSO Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, BITGF is priced at $15.01, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SVSO's P/E ratio is -0.01. In terms of profitability, BITGF's ROE is +0.04%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, BITGF is more volatile compared to SVSO. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check SVSO's competition here
BITGF vs LFPI Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, LFPI has a market cap of 2.1K. Regarding current trading prices, BITGF is priced at $15.01, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas LFPI's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, BITGF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check LFPI's competition here
BITGF vs SEYE Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, BITGF is priced at $15.01, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SEYE's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to SEYE's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check SEYE's competition here
BITGF vs BGMD Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, BITGF is priced at $15.01, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas BGMD's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to BGMD's ROE of +7.47%. Regarding short-term risk, BITGF is more volatile compared to BGMD. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check BGMD's competition here
BITGF vs ADLI Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, BITGF is priced at $15.01, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas ADLI's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, BITGF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check ADLI's competition here
BITGF vs VSMD Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, VSMD has a market cap of 802. Regarding current trading prices, BITGF is priced at $15.01, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas VSMD's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, BITGF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check VSMD's competition here
BITGF vs TEVNF Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, TEVNF has a market cap of 744. Regarding current trading prices, BITGF is priced at $15.01, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas TEVNF's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, BITGF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check TEVNF's competition here
BITGF vs MICRD Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, MICRD has a market cap of 317. Regarding current trading prices, BITGF is priced at $15.01, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas MICRD's P/E ratio is -0.00. In terms of profitability, BITGF's ROE is +0.04%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, BITGF is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check MICRD's competition here
BITGF vs INND Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, INND has a market cap of 306. Regarding current trading prices, BITGF is priced at $15.01, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas INND's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to INND's ROE of -0.01%. Regarding short-term risk, BITGF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for BITGF.Check INND's competition here
BITGF vs HRAL Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, HRAL has a market cap of 297. Regarding current trading prices, BITGF is priced at $15.01, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas HRAL's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to HRAL's ROE of +0.21%. Regarding short-term risk, BITGF is more volatile compared to HRAL. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check HRAL's competition here
BITGF vs RGBOQ Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, BITGF is priced at $15.01, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, BITGF's ROE is +0.04%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check RGBOQ's competition here
BITGF vs SECI Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, SECI has a market cap of 31. Regarding current trading prices, BITGF is priced at $15.01, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas SECI's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to SECI's ROE of -0.00%. Regarding short-term risk, BITGF is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check SECI's competition here
BITGF vs VTEQ Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, BITGF is priced at $15.01, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, BITGF's ROE is +0.04%, compared to VTEQ's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check VTEQ's competition here
BITGF vs MEDVD Comparison June 2026
BITGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BITGF stands at 1.2B. In comparison, MEDVD has a market cap of 0. Regarding current trading prices, BITGF is priced at $15.01, while MEDVD trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BITGF currently has a P/E ratio of 45.50, whereas MEDVD's P/E ratio is N/A. In terms of profitability, BITGF's ROE is +0.04%, compared to MEDVD's ROE of N/A. Regarding short-term risk, BITGF is more volatile compared to MEDVD. This indicates potentially higher risk in terms of short-term price fluctuations for BITGF.Check MEDVD's competition here